West Pharmaceutical Services Inc (WST)
323.32
-6.06
(-1.84%)
USD |
NYSE |
Nov 07, 16:00
323.32
0.00 (0.00%)
After-Hours: 18:36
West Pharmaceutical Services Revenue (Annual): 2.950B for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.950B |
| December 31, 2022 | 2.887B |
| December 31, 2021 | 2.832B |
| December 31, 2020 | 2.147B |
| December 31, 2019 | 1.840B |
| December 31, 2018 | 1.717B |
| December 31, 2017 | 1.599B |
| December 31, 2016 | 1.509B |
| December 31, 2015 | 1.400B |
| December 31, 2014 | 1.421B |
| December 31, 2013 | 1.368B |
| December 31, 2012 | 1.266B |
| December 31, 2011 | 1.192B |
| December 31, 2010 | 1.105B |
| December 31, 2009 | 1.056B |
| December 31, 2008 | 1.051B |
| December 31, 2007 | 1.020B |
| December 31, 2006 | 913.30M |
| December 31, 2005 | 699.70M |
| December 31, 2004 | 541.60M |
| Date | Value |
|---|---|
| December 31, 2003 | 483.40M |
| December 31, 2002 | 412.80M |
| December 31, 2001 | 392.30M |
| December 31, 2000 | 372.50M |
| December 31, 1999 | 469.10M |
| December 31, 1998 | 449.70M |
| December 31, 1997 | 452.50M |
| December 31, 1996 | 458.80M |
| December 31, 1995 | 412.90M |
| December 31, 1994 | 365.10M |
| December 31, 1993 | 348.70M |
| December 31, 1992 | 338.20M |
| December 31, 1991 | 329.60M |
| December 31, 1990 | 323.20M |
| December 31, 1989 | 308.70M |
| December 31, 1988 | 288.20M |
| December 31, 1987 | 253.30M |
| December 31, 1986 | 235.60M |
| December 31, 1985 | 190.10M |
| December 31, 1984 | 182.20M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
1.840B
Minimum
2019
2.950B
Maximum
2023
2.531B
Average
2.832B
Median
2021
Revenue (Annual) Benchmarks
| Repligen Corp | 638.76M |
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 43.60M |
| Xtant Medical Holdings Inc | 91.30M |
| Catheter Precision Inc | 0.442M |